Company Filing History:
Years Active: 2025
Title: Terje Wimberger: Innovator in Electroporation and Cell Treatment
Introduction
Terje Wimberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biological cell treatment, particularly through his innovative methods of electroporation and lysis of eukaryotic cells. With a total of 2 patents, his work is paving the way for advancements in biological research and applications.
Latest Patents
Wimberger's latest patents include a method for specific electroporation and lysis of eukaryotic cells. This method targets eukaryotic cellular bodies in a biological sample, which are categorized into at least two subgroups with varying susceptibilities to electroporation and lysis in electric fields. The process involves transferring the biological sample into a chamber and exposing it to an electric field generated by at least two electrodes coated with a dielectric material. The electric parameters are carefully selected to ensure that the subgroups are affected differently, allowing for precise electroporation and lysis. Another significant patent focuses on coupled sorting and electric treatment of biological cells, providing a method for lysis or electroporation of cells in a biological sample.
Career Highlights
Terje Wimberger is associated with the AIT Austrian Institute of Technology GmbH, where he continues to develop and refine his innovative techniques. His work is instrumental in enhancing the understanding and manipulation of biological cells, which has far-reaching implications in various scientific fields.
Collaborations
Wimberger collaborates with esteemed colleagues such as Klemens Wassermann and Johannes Peham. Their combined expertise contributes to the advancement of research and development in the field of biological treatments.
Conclusion
Terje Wimberger's contributions to the field of electroporation and cell treatment exemplify the impact of innovation in biological research. His patents and collaborative efforts are set to influence future advancements in the manipulation of eukaryotic cells.